Our Work, Neuro-Bio

Press conference to secure media coverage

The challenge

Biotech company Neuro-Bio approached us to organise a press conference in London and secure media coverage ahead of their Series B fundraiser.

Goals were to communicate results of Neuro-Bio’s scientific study, tell the story of their Alzheimer’s drug, and create supporting branded materials.

Our approach

We created a top-tier media coverage campaign with a focus on credibility and accuracy

Working with Neuro-Bio, we spoke with leading science journalists and helped pull together a panel of experts to answer questions at a live press conference. We invited a targeted group to attend the press conference in London and managed virtual attendance of journalists worldwide.

We focused on publications suitable for building Neuro-Bio’s reputation in the business and science communities, and worked with them to create supporting materials, including a press release, a media Q&A, graphics and a company leaflet.

The results

The result was a successful conference with global coverage of highlights in the press

47 pieces of coverage of the research
864 K estimated views
525 M audience size
1.31 K engagements

Securing top-tier media coverage was a key goal ahead of our Series B fundraise. Sciad’s expertise and knowledge of the science media landscape was evident, and we were extremely pleased with the outcomes of the press conference.

– Baroness Greenfield, Founder and CEO of Neuro-Bio

Need help getting media coverage?

We’d love to hear from you! Head to our contact page to start a conversation.